Coverage
-
November 01, 2019
AstraZeneca has urged a New York federal judge to transfer consolidated proposed class actions accusing the company of paying off generic-drug makers to protect its brand antipsychotic drug Seroquel XR, arguing the cases belong in Delaware if they are not tossed outright.
1 other articles on this case.
View all »